AU588299B2
(en)
*
|
1985-04-08 |
1989-09-14 |
Rafa Laboratories Ltd. |
Artificial microcompartmentalization
|
US5409704A
(en)
*
|
1985-06-26 |
1995-04-25 |
The Liposome Company, Inc. |
Liposomes comprising aminoglycoside phosphates and methods of production and use
|
DE3689769T2
(de)
*
|
1985-07-05 |
1994-07-21 |
Liposome Co Inc |
Multilamellare liposome mit verbesserter einschliessungswirkung.
|
FR2628317B1
(fr)
*
|
1988-03-09 |
1991-11-08 |
Lvmh Rech |
Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de scutellaria, ou au moins un flavonoide tel que baicaleine ou baicaline et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite anti-allergique, anti-inflammatoire ou anti-vieillissement, l'incorporant
|
MX9203504A
(es)
*
|
1988-04-20 |
1992-07-01 |
Liposome Co Inc |
Complejo agente: lipido activo de alta proporcion.
|
DE68916956T2
(de)
*
|
1988-05-20 |
1994-11-24 |
Liposome Co Inc |
Aktives mittel: lipid-komplex mit hohem verhältnis.
|
US5269979A
(en)
*
|
1988-06-08 |
1993-12-14 |
Fountain Pharmaceuticals, Inc. |
Method for making solvent dilution microcarriers
|
IL90561A
(en)
*
|
1988-06-08 |
1993-08-18 |
Fountain Pharm Inc |
Method for making solvent dilution microcarriers
|
US4952405A
(en)
*
|
1988-10-20 |
1990-08-28 |
Liposome Technology, Inc. |
Method of treating M. avium infection
|
JP2955314B2
(ja)
*
|
1988-10-27 |
1999-10-04 |
リージェンツ・オブ・ザ・ユニバーシティー・オブ・ミネソタ |
Il―2含有リポソーム免疫アジュバント
|
ES2116983T3
(es)
*
|
1989-05-25 |
1998-08-01 |
Technology Unlimited Inc |
Ahuyentador de insectos.
|
NZ237464A
(en)
*
|
1990-03-21 |
1995-02-24 |
Depotech Corp |
Liposomes with at least two separate chambers encapsulating two separate biologically active substances
|
US5264220A
(en)
*
|
1991-11-12 |
1993-11-23 |
Long David M Jr |
Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents
|
CA2127107C
(en)
*
|
1991-12-31 |
2007-06-19 |
Bruce L. A. Carter |
Methods and compositions for reducing blood loss
|
EP0585514B1
(en)
*
|
1992-01-09 |
1998-10-07 |
LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d., Ljubljana |
Animal feed and an additive thereto or to drinking water containing an antibiotic mixture of gentamicin with lincomycin or clindamycin
|
US5344822A
(en)
*
|
1992-08-12 |
1994-09-06 |
The Rogosin Institute |
Methods useful in endotoxin prophylaxis and therapy
|
US5674855A
(en)
*
|
1992-08-12 |
1997-10-07 |
The Rogosin Institute |
Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
|
WO1994012155A1
(en)
*
|
1992-12-02 |
1994-06-09 |
Vestar, Inc. |
Antibiotic formulation and process
|
US5958449A
(en)
*
|
1992-12-02 |
1999-09-28 |
Nexstar Pharmaceuticals, Inc. |
Antibiotic formulation and use for bacterial infections
|
US5759571A
(en)
*
|
1993-05-11 |
1998-06-02 |
Nexstar Pharmaceuticals, Inc. |
Antibiotic formulation and use for drug resistant infections
|
US5478819A
(en)
*
|
1993-06-23 |
1995-12-26 |
Simo Tarpila |
Phospholipid composition and use thereof
|
DE69430823T2
(de)
*
|
1993-09-22 |
2003-02-20 |
Xoma Technology Ltd |
Verfahren zur behandlung von gram-negativen bakterien infektion durch verabreichung von bakterientötendem/durchlässigkeiterhöhendem (bpi) proteinprodukt und antibiotikum
|
EP0664117A1
(de)
*
|
1994-01-25 |
1995-07-26 |
F. Hoffmann-La Roche Ag |
Liposomenlösungen
|
US20020028215A1
(en)
|
1999-08-09 |
2002-03-07 |
Jagath L. Kadurugamuwa |
Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
|
US6096336A
(en)
*
|
1996-01-30 |
2000-08-01 |
The Stehlin Foundation For Cancer Research |
Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
|
US6071535A
(en)
*
|
1996-01-31 |
2000-06-06 |
Collaborative Laboratories, Inc. |
Lipid vesicles formed with alkylammonium fatty acid salts
|
US5874105A
(en)
*
|
1996-01-31 |
1999-02-23 |
Collaborative Laboratories, Inc. |
Lipid vesicles formed with alkylammonium fatty acid salts
|
US6183774B1
(en)
|
1996-01-31 |
2001-02-06 |
Collaborative Laboratories, Inc. |
Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
|
BR9710665A
(pt)
|
1996-05-08 |
1999-08-17 |
Biogen Inc |
Compostos que promovem o desenvolvimento do tecido
|
WO1998006435A2
(en)
*
|
1996-08-14 |
1998-02-19 |
Vanderbilt University |
COMPOSITIONS OF ANTICHLAMYDIAL AGENTS FOR THE DIAGNOSIS AND MANAGEMENT OF INFECTION CAUSED BY $i(CHLAMYDIA)
|
US5935572A
(en)
*
|
1997-01-10 |
1999-08-10 |
Collaborative Laboratories, Inc. |
Composition containing protease separate from glycosidase for removing nits in treating lice infestation
|
US6613352B2
(en)
|
1999-04-13 |
2003-09-02 |
Universite De Montreal |
Low-rigidity liposomal formulation
|
US6352996B1
(en)
|
1999-08-03 |
2002-03-05 |
The Stehlin Foundation For Cancer Research |
Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
|
AU2002334761A1
(en)
*
|
2001-10-01 |
2003-04-14 |
The Board Of Trustees Of The University Of Illinois |
Methods of treating drug-resistant bacterial infections
|
CA2383259A1
(en)
|
2002-04-23 |
2003-10-23 |
Celator Technologies Inc. |
Synergistic compositions
|
US20080075762A1
(en)
*
|
2001-10-03 |
2008-03-27 |
Paul Tardi |
Compositions for delivery of drug combinations
|
US7850990B2
(en)
|
2001-10-03 |
2010-12-14 |
Celator Pharmaceuticals, Inc. |
Compositions for delivery of drug combinations
|
WO2003070181A2
(en)
*
|
2002-02-19 |
2003-08-28 |
Eden Research Plc |
Compositions and methods for preservation of food
|
CA2477979A1
(en)
*
|
2002-03-05 |
2003-09-18 |
Transave, Inc. |
An inhalation system for treatment of intracellular infections
|
US7879351B2
(en)
*
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
EP2363114B1
(en)
*
|
2002-10-29 |
2015-05-20 |
Insmed Incorporated |
Sustained release of antiinfectives
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
US6846966B2
(en)
*
|
2002-11-26 |
2005-01-25 |
Exxonmobil Chemical Patents Inc. |
Method and apparatus for treating oxygenate-containing feeds and their use in conversion of oxygenates to olefins
|
FR2852513A1
(fr)
*
|
2003-03-17 |
2004-09-24 |
Groupe Lepine |
Combinaison d'antibiotiques gentamicine/clindamycine et ses applications aux ciments orthopediques curatifs
|
CA2521120A1
(en)
|
2003-04-02 |
2004-10-21 |
The Government Of The United States Of America As Represented By The Sec Retary, Department Of Health And Human Services |
Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi
|
US20040204435A1
(en)
*
|
2003-04-09 |
2004-10-14 |
Joachim Liehr |
Alternating treatment with topoisomerase I and topoisomerase II inhibitors
|
CN1950397B
(zh)
|
2004-03-30 |
2012-05-16 |
Ns基因公司 |
生长因子NsG33的治疗用途
|
WO2006013462A2
(en)
*
|
2004-07-30 |
2006-02-09 |
Nsgene A/S |
Growth factors nsg28, nsg30, and nsg32
|
WO2006032136A1
(en)
*
|
2004-09-20 |
2006-03-30 |
British Columbia Cancer Agency Branch |
Free or liposomal gemcitabine alone or in combination with free or liposomal idarubicin
|
US20110020434A1
(en)
*
|
2005-09-02 |
2011-01-27 |
O'halloran Thomas V |
Nanoparticle arsenic-platinum compositions
|
DE102005063375A1
(de)
*
|
2005-09-15 |
2007-04-19 |
Schülke & Mayr GmbH |
Antimikrobielle Zubereitungen mit einem Gehalt an Octenidindihydrochlorid verkapselt in Liposomen
|
BRPI0618643A2
(pt)
|
2005-11-09 |
2011-09-06 |
Combinatorx Inc |
composição compreendendo um par de fármacos, composição compreendendo um corticosteróide e um imunossupressor dependente de imunofilina não-esteróide, kits e uso
|
EP1962805B1
(en)
|
2005-12-08 |
2016-07-06 |
Insmed Incorporated |
Lipid-based compositions of antiinfectives for treating pulmonary infections
|
US20100196455A1
(en)
|
2007-05-04 |
2010-08-05 |
Transave, Inc. |
Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
US8470762B2
(en)
*
|
2007-05-31 |
2013-06-25 |
Colgate-Palmolive Company |
Fabric softening compositions comprising polymeric materials
|
WO2009108407A1
(en)
*
|
2008-02-25 |
2009-09-03 |
The University Of North Carolina At Charlotte Office Of Technology Transfer |
Biodegradable therapeutic nanoparticles containing an antimicrobial agent
|
US8039450B2
(en)
|
2008-03-06 |
2011-10-18 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules as anti-inflammatory agents
|
CN102725401A
(zh)
|
2009-07-10 |
2012-10-10 |
哈佛大学校长及研究员协会 |
作为抗炎药的永久带电荷的钠和钙通道阻断剂
|
WO2011075688A1
(en)
|
2009-12-18 |
2011-06-23 |
Exodos Life Sciences Limited Partnership |
Methods and compositions for treating and preventing trigeminal autonomic cephalgias, migraine, and vascular conditions
|
US8716478B2
(en)
|
2010-01-27 |
2014-05-06 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules
|
WO2011157275A1
(en)
|
2010-06-14 |
2011-12-22 |
H. Lundbeck A/S |
Modulation of the interaction between sorla and gdnf-family ligand receptors
|
EP2595634B1
(en)
*
|
2010-07-23 |
2016-09-14 |
Acea Biotech, Inc. |
Antifungal and antiparasitic polyene macrolides
|
CN103269708A
(zh)
|
2010-10-01 |
2013-08-28 |
Ns基因公司 |
镍纹蛋白用于治疗异常性疼痛、痛觉过敏、自发性疼痛和幻痛的用途
|
AU2013266400B2
(en)
|
2012-05-21 |
2017-06-22 |
Insmed Incorporated |
Systems for treating pulmonary infections
|
EP3581186A1
(en)
|
2012-11-29 |
2019-12-18 |
Insmed Incorporated |
Stabilized vancomycin formulations
|
US9895385B2
(en)
|
2014-05-15 |
2018-02-20 |
Insmed Incorporated |
Methods for treating pulmonary non-tuberculous mycobacterial infections
|
US10791740B2
(en)
*
|
2014-06-06 |
2020-10-06 |
The Curators Of The University Of Missouri |
Enhancement of antibiotic efficacy
|
US20170266106A1
(en)
|
2014-12-01 |
2017-09-21 |
Achelios Therapeutics, Inc. |
Methods and compositions for treating migraine and conditions associated with pain
|
JP6833811B2
(ja)
|
2015-08-03 |
2021-02-24 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
荷電イオンチャネル遮断薬及び使用方法
|
AU2017312116A1
(en)
|
2016-08-17 |
2019-03-07 |
Solstice Biologics, Ltd. |
Polynucleotide constructs
|
WO2019006455A1
(en)
|
2017-06-30 |
2019-01-03 |
Solstice Biologics, Ltd. |
AUXILIARIES OF CHIRAL PHOSPHORAMIDITIS AND METHODS OF USE THEREOF
|
US11571386B2
(en)
|
2018-03-30 |
2023-02-07 |
Insmed Incorporated |
Methods for continuous manufacture of liposomal drug products
|
CA3129089A1
(en)
|
2019-03-11 |
2020-09-17 |
Bridget Mccarthy Cole |
Ester substituted ion channel blockers and methods for use
|
US10780083B1
(en)
|
2019-03-11 |
2020-09-22 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
CN113811305A
(zh)
|
2019-03-11 |
2021-12-17 |
诺西恩医疗公司 |
带电的离子通道阻滞剂及其使用方法
|
JP2022527690A
(ja)
|
2019-03-11 |
2022-06-03 |
ノシオン セラピューティクス,インコーポレイテッド |
荷電したイオンチャンネル遮断薬および使用方法
|
US10828287B2
(en)
|
2019-03-11 |
2020-11-10 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
US10933055B1
(en)
|
2019-11-06 |
2021-03-02 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
WO2021091585A1
(en)
|
2019-11-06 |
2021-05-14 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
CA3170070A1
(en)
|
2020-03-11 |
2021-09-16 |
Bridget Mccarthy Cole |
Charged ion channel blockers and methods for use
|
EP4333872A1
(en)
|
2021-05-06 |
2024-03-13 |
Hoba Therapeutics ApS |
Prevention and treatment of chemotherapy-induced neuropathic pain
|
WO2023104960A1
(en)
|
2021-12-10 |
2023-06-15 |
Hoba Therapeutics Aps |
Treatment of nociceptive pain
|